CPSC2021-01-14
Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
Scalpa Inc., of Phoenix, Ariz.
Hazard
The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.
Remedy
Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.
Sold at
Scalpashop.com and Amazon.com from February 2020 through November 2020 for about $18.
Affected count
About 10,000
Injuries reported
None reported.
Manufactured in
China
Remedy type
Refund
Products
Scalpa Numb Maximum Strength Topical Anesthetic Cream
Consumer contact
Scalpa toll-free at 855-424-7828 from 9 a.m. to 5 p.m. MT Monday through Friday, by email at care@scalpashop.com or online at www.scalpashop.com and click on “Recall - Important Safety Information - Scalpa Numb” for more information.
Official notice
https://www.cpsc.gov/Recalls/2021/Scalpa-Recalls-Scalpa-Numb-Maximum-Strength-Topical-Anesthetic-Cream-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning-Recall-AlertDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief